Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Keeping Track: US FDA Drugs Center Passes 50 Novel Agent Approvals In 2023

Nov 18 2023

• By Bridget Silverman

50th cake — • Source: Shutterstock

Related Content

FDA Panel Rejects Merck’s Gefapixant For Chronic Cough, Calls For Better Endpoints

Nov 18 2023

A Month After Lung Cancer Withdrawal, Takeda Gets Approval For New Colorectal Cancer Drug

Nov 09 2023

AstraZeneca Wins The AKT Race With Truqap

Nov 17 2023

BMS Grows Its Lung Cancer Portfolio With ‘Best-In-Class’ Augtyro Approval

Nov 16 2023

Related Companies

Evive Biotech

AstraZeneca PLC

SpringWorks Therapeutics Inc.

Ionis Pharmaceuticals, Inc.

Coherus Oncology, Inc.

Junshi Biosciences/Immorna Joint Venture

Astellas Pharma, Inc.

Vertex Pharmaceuticals Incorporated

CRISPR Therapeutics AG

Genetix Biotherapeutics

Bristol Myers Squibb Company

Takeda Pharmaceutical Co. Ltd.

CorMedix Inc.

Insmed Incorporated

Mylan Pharmaceuticals Inc.

Additional Topics

United States Approvals Drug Review Drug Approval Standards Regulation US FDA Performance Tracker BioPharmaceutical

More from US FDA Performance Tracker

More from Regulatory Trackers

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window